David Kirn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David kirn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Kirn Today - Breaking & Trending Today

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Buy" by Brokerages

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Scott Bizily , David Kirn , Affinity Wealth Management , T Bank Corp , Goldman Sachs Group , Jefferies Financial Group , D Molecular Therapeutics Inc , Sg Americas Securities , Mt Bank Corp , York Mellon Corp , Securities Exchange Commission , Panagora Asset Management Inc , Molecular Therapeutics , Get Free Report , Exchange Commission , Wealth Management , New York Mellon Corp , Asset Management , Get Free , Molecular Therapeutics Daily ,

Bfsg LLC Takes Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Bfsg LLC acquired a new stake in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other hedge funds have also recently modified their holdings of FDMT. RA Capital Management L.P. boosted […] ....

United States , Dekabank Deutsche Girozentrale , Scott Bizily , David Kirn , Goldman Sachs Group , Vontobel Holding Ltd , Royal Bank , Holdings Channel , Panagora Asset Management Inc , D Molecular Therapeutics Inc , Jefferies Financial Group , Molecular Therapeutics , Free Report , Asset Management , Bank Deutsche Girozentrale , Trexquant Investment , Molecular Therapeutics Stock Down , Get Free Report , Visit Holdingschannel , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Bfsg LLC Acquires New Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Bfsg LLC acquired a new stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other institutional investors and hedge funds […] ....

United States , David Kirn , Scott Bizily , Panagora Asset Management Inc , Mt Bank Corp , T Bank Corp , Sg Americas Securities , D Molecular Therapeutics Inc , Jefferies Financial Group , Goldman Sachs Group , York Mellon Corp , Affinity Wealth Management , Molecular Therapeutics , Free Report , Wealth Management , New York Mellon Corp , Asset Management , Financial Group , Molecular Therapeutics Trading Down , Get Free Report , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 2.3%

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) were down 2.3% during trading on Wednesday . The company traded as low as $26.13 and last traded at $26.13. Approximately 43,923 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 1,080,685 shares. The stock had previously […] ....

Nova Scotia , United States , Scott Bizily , David Kirn , Novo Holdings , Securities Exchange Commission , D Molecular Therapeutics Inc , Blackrock Inc , Goldman Sachs Group Inc , Jefferies Financial Group , Royal Bank , Molecular Therapeutics , Get Free Report , Financial Group , Molecular Therapeutics Trading Down , Exchange Commission , Street Corp , Sachs Group , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt ,